When was Omics2Image founded?

Omics2Image was founded in 2012 and raised its 1st funding round 1 year after it was founded.

Where is Omics2Image located?

Omics2Image is headquartered in Amsterdam, Netherlands.

Is Omics2Image a funded company?

Omics2Image is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Jun 14, 2013.

When was the latest funding round of Omics2Image?

Omics2Image's latest funding was a $***** Seed round on Jun 14, 2013, with participation from 1 investor. Its primary sector is Life Sciences Platforms and Tools. Globally, the Life Sciences Platforms and Tools sector has seen $600M in funding in 2026 to date.

Where does Omics2Image rank among its competitors?

Omics2Image ranks 116th amongst 120 active competitors, of which 34 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Exum, which secured $120K in Dec, 2025.

Who are the top competitors of Omics2Image?

Omics2Image's top competitors include 908 Devices, MOBILion Systems and Advion. Among them, Exum secured the most recent funding round in December, 2025.

Omics2Image - 2026 Company Profile, Team, Funding & Competitors

Company Details

Omics2Image offers biomolecular imaging and mass spectrometry solutions. Its product IonPix camera is an imaging detector for ToF based mass spectrometry systems and is available as OEM and retrofit model. The camera generates a mass-resolved image in a single measurement cycle. It facilitates parallel detection of multiple molecular species and accommodates significantly more ion hits simultaneously and can be used for large area, high-resolution imaging. It can be used for antibody characterization, beam monitoring, True MS imaging and to detect intact proteins, antibodies, metabolites, lipids, and more biomarkers.

Website: omics2image.com
Email ID: *****@omics2image.com

Key Metrics

Founded Year

2012

Location

Amsterdam, Netherlands

Stage

Seed

Total Funding

$28.3K in 1 round

Latest Funding Round

Seed, Jun 14, 2013, $*****

Investors

1&12 Ventures

Ranked

116^th among 120 active competitors

Similar Companies

908 Devices & 62 more

View Omics2Image's full profile

Omics2Image has raised a total funding of $28.3K over 1 round. Its latest funding round was a Seed round on Jun 14, 2013 for $*****. 1 investor participated in its latest round. Omics2Image has 1 institutional investor.

Here is the list of recent funding rounds of Omics2Image:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 14, 2013	5484233	Seed	6086344	7426369	9623946	5776630

Access funding benchmarks and valuations. Sign up today!

View details of Omics2Image's funding rounds and investors

The founders of Omics2Image are Hans Roeland Poolman and Ron Heeren.

Here are the details of Omics2Image's key team members:

Hans Roeland Poolman: Former Co-Founder of Omics2Image and founder of 1 other company.
Ron Heeren: Co-Founder of Omics2Image.

View details of Omics2Image's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Omics2Image include 908 Devices, MOBILion Systems and Advion. Here is the list of Top 10 competitors of Omics2Image, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	908 Devices 2012, Boston (United States), Public	Manufacturer of detection device for chemical analysis using mass spectrometry	$68.2M	In-Q-Tel, Tao Capital Partners & 10 others	70/100
2nd	MOBILion Systems 2015, Philadelphia (United States), Series C	Manufacturer of mass spectroscopy instruments for clinical solutions	$114M	Agilent, aMoon & 8 others	58/100
3rd	Advion 1993, Ithaca (United States), Acquired	Mass spectrometry, chromatography, and purification solutions for scientific advancement	$45.6M	Aisling Capital, Polaris Partners & 3 others	50/100
4th	Linear Diagnostics 2011, Birmingham (United Kingdom), Seed	Developer of a molecular diagnostic test for sexually transmitted infections	$4.08M	Midven, Future Planet Capital & 9 others	49/100
5th	Refeyn 2018, Oxford (United Kingdom), Series B	Developer of a technology for the measurement of single molecular mass	$32.9M	Northpond Ventures, Oxford Science Enterprises ... & 11 others	49/100
6th	Exum 2017, Denver (United States), Series A	Provider of tools and instruments for research	$11.2M	EIC Rose Rock, Alchemy Capital Management ... & 9 others	47/100
7th	Anvajo 2016, Dresden (Germany), Series A	Provider of point-of-care solutions for laboratory diagnostics	$17.3M	Think.Health, Sanno Capital & 22 others	47/100
8th	Rigaku 1951, Tokyo (Japan), Acquired	Provider of XRD, XRF, SAXS, Raman, metrology and crystallography solutions	-	Europa	46/100
9th	Speclipse 2015, Seongnam-si (South Korea), Acquired	Provider of molecular spectroscopy systems for early-stage skin cancer detection	$10.6M	SBVA, InterVest & 9 others	46/100
10th	Spectra Analysis 2004, Boston (United States), Acquired	Provider of infrared spectroscopic instruments for molecular analysis	$9.25M	NMT Capital, MassVentures & 1 others	45/100
116th	Omics2Image 2012, Amsterdam (Netherlands), Seed	Biomolecular Imaging and Mass Spectrometry solutions	$28.3K	1&12 Ventures	17/100